Dublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Mutation Detection Kits in Genome Editing Market Report 2025" has been added to ResearchAndMarkets.com's offering. The mutation detection kits in the ...
George: The phase 1/2 study is evaluating a new compound called DCC-3009. It is a drug that was designed specifically to work ...
The APIS ESR1 Mutations Kit is an advanced qPCR assay for the detection of mutations within the estrogen receptor gene. The ESR1 Mutations Kit is described by the company as a qualitative test, ...
It can assess patients’ suitability for Amgen’s colorectal cancer drug, Vectibix. Canadian regulatory authorities approved DxS’ TheraScreen K-RAS Mutation Kit for use as a diagnostic for anti-EGFR ...
Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG ...
Assures 100x upgraded detection sensitivity compare to ddPCR Higher the possibility of precision medicine in the 1st and 2nd stages of cancer patients SEOUL, South Korea--(BUSINESS WIRE)--GENECAST, ...
Hosted on MSN
Health Ministry said to flag error in genetic test kit detecting rare mutation, reread results
The Health Ministry’s discovery of a malfunction in test kits used to detect a genetic mutation especially common among Ashkenazi Jews has reportedly led to the formation of a special review committee ...
(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in mutation detection kits for genome editing include addressing rising genetic disorders with precise diagnostics, leveraging innovations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback